Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

22 December 2018 : Clinical Research  

Evaluation of Two Simple Functional Tests to Predict Attrition from Combat Service in Female Light Infantry Soldiers

Uri Gottlieb12ABCDEF*, Dor Kelman1B, Shmuel Springer2DEF

DOI: 10.12659/MSM.911672

Med Sci Monit 2018; 24: CLR9334-9341

Abstract

BACKGROUND: Worldwide, there is a high attrition rate, or dropout rate, from combat in trained soldiers, mainly due to musculoskeletal injuries. This study aimed to determine whether the use of an upper limb stability test, the Upper Quarter Y-Balance Test (UQYBT), and a modified version of the Ranger Test (MRT) that included a lower limb step-up endurance test, could predict attrition from combat service in female infantry soldiers.

MATERIAL AND METHODS: In 2015, a group of 167 newly recruited female light infantry soldiers were evaluated using the UQYBT and the MRT. Data regarding attrition from combat service were collected in 2017, 18 months after screening. Multiple logistic regression analysis was used to determine the predictive effect of body mass index (BMI), UQYBT, and MRT scores on attrition from combat service.

RESULTS: Fifty-three female soldiers (31.7%) dropped out of combat service during the 18 months following recruitment. The MRT score was a significant predictor of attrition, with each additional incremental increase in the MRT score reducing the attrition rate by 6.8% (OR=0.934; 95% CI, 0.895–0.975). A cutoff MRT score of 12 increments predicted attrition with 73.7% sensitivity and 50.9% specificity. The UQYBT scores and BMI were not significant predictors.

CONCLUSIONS: The use of the MRT during military training, was a predictive screening method to predict attrition from combat service in Israeli female infantry soldiers. Further studies are required to evaluate the use of the MRT in other groups of women in the military.

Keywords: Cumulative Trauma Disorders, Mass Screening, Military Science

Add Comment 0 Comments

Editorial

01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

Clinical Research  

Differential Inflammatory Responses in Adult and Pediatric COVID-19 Patients: Implications for Long-Term Co...

Med Sci Monit In Press; DOI: 10.12659/MSM.944052  

Clinical Research  

Effectiveness of Shoulder Taping in Treating Hemiplegic Shoulder Subluxation: A Randomized Controlled Study...

Med Sci Monit In Press; DOI: 10.12659/MSM.944222  

Clinical Research  

Comparison of Fentanyl, Ketamine, and Lidocaine Combined with Propofol Anesthesia in Patients with Crohn Di...

Med Sci Monit In Press; DOI: 10.12659/MSM.944116  

Database Analysis  

ANXA5: A Key Regulator of Immune Cell Infiltration in Hepatocellular Carcinoma

Med Sci Monit In Press; DOI: 10.12659/MSM.943523  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750